Search research articles
Contact Us
Filters
Showing results (21-30 of 136) with videos related to
Page
of 14
Sort By:
The British Journal of Dermatology
|
August 17, 2006
Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma
F C Muchemwa, T Nakatsura, H Ihn, et al.
Clinical and Experimental Dermatology
|
August 12, 2009
PDGFB quantification is a useful tool in the diagnosis of dermatofibrosarcoma protuberans: a study of 10 cases
F C Muchemwa, S Wakasugi, Y Honda, et al.
Archives of Dermatology
|
October 1, 1994
Antigen specificity of antihistone antibodies in localized scleroderma
S Sato, M Fujimoto, H Ihn, et al.
The British Journal of Dermatology
|
May 1, 1996
Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma
H Ihn, S Sato, M Fujimoto, et al.
British Journal of Rheumatology
|
December 16, 1998
Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis
H Ihn, S Sato, M Fujimoto, et al.
Archives of Dermatological Research
|
April 5, 2000
Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody
S Sato, M Hasegawa, H Ihn, et al.
Archives of Dermatology
|
October 1, 1994
Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma
K Kikuchi, S Sato, T Kadono, et al.
Dermatology (Basel, Switzerland)
|
March 13, 2001
The successful treatment of prurigo pigmentosa with macrolide antibiotics
N Yazawa, H Ihn, K Yamane, et al.
The Journal of Rheumatology
|
August 24, 2000
Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma
T Nagaoka, S Sato, M Hasegawa, et al.
Clinical and Experimental Dermatology
|
September 7, 2004
Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome
Y Tsunemi, Y Tada, H Saeki, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 136) with videos related to
Sort By:
Page
of 14
The British Journal of Dermatology
|
August 17, 2006
Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma
F C Muchemwa, T Nakatsura, H Ihn, et al.
Clinical and Experimental Dermatology
|
August 12, 2009
PDGFB quantification is a useful tool in the diagnosis of dermatofibrosarcoma protuberans: a study of 10 cases
F C Muchemwa, S Wakasugi, Y Honda, et al.
Archives of Dermatology
|
October 1, 1994
Antigen specificity of antihistone antibodies in localized scleroderma
S Sato, M Fujimoto, H Ihn, et al.
The British Journal of Dermatology
|
May 1, 1996
Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma
H Ihn, S Sato, M Fujimoto, et al.
British Journal of Rheumatology
|
December 16, 1998
Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis
H Ihn, S Sato, M Fujimoto, et al.
Archives of Dermatological Research
|
April 5, 2000
Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody
S Sato, M Hasegawa, H Ihn, et al.
Archives of Dermatology
|
October 1, 1994
Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma
K Kikuchi, S Sato, T Kadono, et al.
Dermatology (Basel, Switzerland)
|
March 13, 2001
The successful treatment of prurigo pigmentosa with macrolide antibiotics
N Yazawa, H Ihn, K Yamane, et al.
The Journal of Rheumatology
|
August 24, 2000
Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma
T Nagaoka, S Sato, M Hasegawa, et al.
Clinical and Experimental Dermatology
|
September 7, 2004
Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome
Y Tsunemi, Y Tada, H Saeki, et al.
Page
of 14